1. Home
  2. IPSC vs ATLO Comparison

IPSC vs ATLO Comparison

Compare IPSC & ATLO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IPSC
  • ATLO
  • Stock Information
  • Founded
  • IPSC 2019
  • ATLO 1903
  • Country
  • IPSC United States
  • ATLO United States
  • Employees
  • IPSC N/A
  • ATLO N/A
  • Industry
  • IPSC Medicinal Chemicals and Botanical Products
  • ATLO Major Banks
  • Sector
  • IPSC Health Care
  • ATLO Finance
  • Exchange
  • IPSC Nasdaq
  • ATLO Nasdaq
  • Market Cap
  • IPSC 146.2M
  • ATLO 144.8M
  • IPO Year
  • IPSC 2021
  • ATLO N/A
  • Fundamental
  • Price
  • IPSC $1.10
  • ATLO $16.44
  • Analyst Decision
  • IPSC Strong Buy
  • ATLO
  • Analyst Count
  • IPSC 4
  • ATLO 0
  • Target Price
  • IPSC $13.00
  • ATLO N/A
  • AVG Volume (30 Days)
  • IPSC 864.2K
  • ATLO 24.2K
  • Earning Date
  • IPSC 11-05-2024
  • ATLO 01-17-2025
  • Dividend Yield
  • IPSC N/A
  • ATLO 6.14%
  • EPS Growth
  • IPSC N/A
  • ATLO N/A
  • EPS
  • IPSC N/A
  • ATLO 0.98
  • Revenue
  • IPSC $2,684,000.00
  • ATLO $51,071,000.00
  • Revenue This Year
  • IPSC $230.56
  • ATLO N/A
  • Revenue Next Year
  • IPSC $31.85
  • ATLO N/A
  • P/E Ratio
  • IPSC N/A
  • ATLO $16.72
  • Revenue Growth
  • IPSC 7.88
  • ATLO N/A
  • 52 Week Low
  • IPSC $0.98
  • ATLO $15.69
  • 52 Week High
  • IPSC $5.51
  • ATLO $22.41
  • Technical
  • Relative Strength Index (RSI)
  • IPSC 36.74
  • ATLO 40.42
  • Support Level
  • IPSC $0.98
  • ATLO $17.13
  • Resistance Level
  • IPSC $1.74
  • ATLO $16.98
  • Average True Range (ATR)
  • IPSC 0.14
  • ATLO 0.46
  • MACD
  • IPSC -0.04
  • ATLO -0.09
  • Stochastic Oscillator
  • IPSC 15.79
  • ATLO 35.56

About IPSC Century Therapeutics Inc.

Century Therapeutics Inc is a biotechnology company specializes in leveraging adult stem cells to develop advanced cell therapy products targeting cancer, autoimmune, and inflammatory diseases. Their innovative approach involves a genetically engineered allogeneic cell therapy platform comprising induced pluripotent stem cells (iPSCs), CRISPR-mediated precision gene editing, proprietary chimeric antigen receptors (CARs), Allo-EvasionTM technology, and cutting-edge manufacturing capabilities. This comprehensive platform aims to overcome the limitations of first-generation cell therapies by optimizing cell product performance, preventing rejection by the host immune system, and minimizing development and supply risks.

About ATLO Ames National Corporation

Ames National Corporation is a United States-based bank holding company. Through its subsidiaries, it provides checking, savings and time deposits, cash management services, merchant credit card processing, safe deposit boxes, wire transfers, direct deposit of payroll and social security checks, and automated/video teller machine access. Its loan portfolio comprises commercial, residential & agricultural real estate loans; agricultural & business operating loans & lines of credit; equipment loans; vehicle loans; personal loans; and mortgage loans. Its operations are conducted in central, north central, and south-central Iowa.

Share on Social Networks: